Companies

Unicycive Therapeutics, Inc. (UNCY) SEC filings

CIK 0001766140 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)675000951000
Net income (USD)-26.6 M-30.5 M-18.1 M
Diluted EPS (USD/shares)-1.67-1.28-1.2

Latest filings

FiledFormDescriptionPeriod
2026-10-01332026-10-01
2026-09-298-KCURRENT REPORT items 5.02,8.01,9.012026-09-28
2026-09-288-KCURRENT REPORT items 8.012026-09-03
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-128-KCURRENT REPORT items 2.02,9.012026-08-12
2026-08-1210-QQUARTERLY REPORT2026-06-30
2026-07-30SCHEDULE 13GSCHEDULE 13G
2026-07-284/A4/A2026-05-14
2026-07-284/A4/A2026-05-14
2026-07-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-028-KCURRENT REPORT items 8.012026-07-02
2026-07-01144144
2026-06-22DEFA14ACURRENT REPORT
2026-06-228-KCURRENT REPORT items 5.072026-06-19
2026-06-15EFFECTEFFECT items ,,
2026-06-154/A4/A2026-05-14
2026-06-154/A4/A2026-05-14
2026-06-154/A4/A2026-05-14
2026-06-154/A4/A2026-05-14
2026-06-154/A4/A2026-05-14
2026-06-154/A4/A2026-05-14
2026-06-11CORRESPCORRESP
2026-06-11UPLOADUPLOAD
2026-06-058-KCURRENT REPORT items 1.01,9.012026-06-05

Forms on file (last 1,000): 8-K 70, 4 49, SCHEDULE 13G/A 26, 10-Q 16, CORRESP 16, SC 13G/A 12, DEFA14A 11, SC 13G 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=UNCY (0.002 USD), /gw/filings/filings?ticker=UNCY&form=8-K, /gw/filings/facts?ticker=UNCY&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange